Variants within super-enhancer regulatory elements associate with epithelial ovarian cancer risk

被引：0

作者：

Reid, Brett M. ^{[1
]}

Permuth-Wey, Jennifer ^{[1
]}

Chen, Y. Ann ^{[1
]}

Lin, Hui-Yi ^{[1
]}

Monteiro, Alvaro ^{[1
]}

Chen, Zhihua ^{[1
]}

Berchuck, Andrew ^{[2
]}

Chenevix-Trench, Georgia ^{[3
]}

Doherty, Jennifer ^{[4
]}

Gayther, Simon ^{[5
]}

Goode, Ellen L. ^{[6
]}

Iversen, Edwin ^{[7
]}

Pearce, Leigh ^{[5
]}

Pharoah, Paul ^{[8
]}

Phelan, Catherine ^{[1
]}

Ramus, Susan ^{[5
]}

Rossing, Mary Anne ^{[9
]}

Schildkraut, Joellen ^{[2
]}

Sellers, Thomas ^{[1
]}

机构：

[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA

[2] Duke Canc Inst, Durham, NC USA

[3] Queensland Inst Med Res, Brisbane, Qld 4006, Australia

[4] Geisel Sch Med Dartmouth, Lebanon, NH USA

[5] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA 90033 USA

[6] Mayo Clin, Rochester, MN USA

[7] Duke Univ, Durham, NC USA

[8] Univ Cambridge, Cambridge, England

[9] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA

来源：

CANCER RESEARCH | 2015年 / 75卷

关键词：

D O I：

10.1158/1538-7445.AM2015-4634

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4634

引用

页数：3

共 50 条

[1] Cancer by super-enhancer
Vaehaerautio, Anna
Taipale, Jussi
SCIENCE, 2014, 346 (6215) : 1291 - 1292
[2] Phase Separation, Super-enhancer, and Cancer
Yoshino, Seiko
CANCER SCIENCE, 2024, 115 : 706 - 706
[3] Biogenesis and regulatory functions of super-enhancer RNAs in cancer cells of the immune system
Guo, Yang Eric
Young, Richard
CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
[4] Super-enhancer landscapes of ovarian cancer reveal novel epigenomic subtypes and targets
Eaton, M.
Johnston, B.
Piotrowska, K.
Collins, C.
Lopez, J.
Knutson, S.
di Tomaso, E.
Carulli, J.
Olson, E.
EUROPEAN JOURNAL OF CANCER, 2018, 103 : E130 - E130
[5] Etiology of super-enhancer reprogramming and activation in cancer
Royce W. Zhou
Ramon E. Parsons
Epigenetics & Chromatin, 16
[6] Etiology of super-enhancer reprogramming and activation in cancer
Zhou, Royce W.
Parsons, Ramon E.
EPIGENETICS & CHROMATIN, 2023, 16 (01)
[7] The molecular understanding of super-enhancer dysregulation in cancer
Yoshino, Seiko
Suzuki, Hiroshi I.
NAGOYA JOURNAL OF MEDICAL SCIENCE, 2022, 84 (02): : 216 - 229
[8] SEanalysis: a web tool for super-enhancer associated regulatory analysis
Qian, Feng-Cui
Li, Xue-Cang
Guo, Jin-Cheng
Zhao, Jian-Mei
Li, Yan-Yu
Tang, Zhi-Dong
Zhou, Li-Wei
Zhang, Jian
Bai, Xue-Feng
Jiang, Yong
Pan, Qi
Wang, Qiu-Yu
Li, En-Min
Li, Chun-Quan
Xu, Li-Yan
Lin, De-Chen
NUCLEIC ACIDS RESEARCH, 2019, 47 (W1) : W248 - W255
[9] Evidence that long non-coding RNA variants associate with epithelial ovarian cancer risk
Sellers, Thomas A.
Reid, Brett M.
Chen, Y. Ann
Lin, Hui-Yi
Richards, Edward
Teer, Jamie
Monteiro, Alvaro
Chen, Zhihua
Berchuck, Andrew
Chenevix-Trench, Georgia
Doherty, Jennifer
Goode, Ellen
Iverson, Edwin
Pearce, Leigh
Pharoah, Paul
Phelan, Catherine
Ramus, Susan
Rossing, Mary Anne
Schildkraut, Joellen
Cheng, Jin
Gayther, Simon
Permuth-Wey, Jennifer
CANCER RESEARCH, 2015, 75
[10] Super-enhancer and genome phase separation in cancer research
Suzuki, Hiroshi I.
Sharp, Phillip A.
CANCER SCIENCE, 2018, 109 : 801 - 801

← 1 2 3 4 5 →